Danielle M. Dunlea
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease.
Journal: American journal of respiratory cell and molecular biology
Published: May 04, 2022
Characterization of the Inflammatory Response to Severe COVID-19 Illness.
Journal: American journal of respiratory and critical care medicine
Published: June 26, 2020
Circulating Truncated Alpha-1 Antitrypsin Glycoprotein in Patient Plasma Retains Anti-Inflammatory Capacity.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 27, 2018
Ataluren, a New Therapeutic for Alpha-1 Antitrypsin-Deficient Individuals with Nonsense Mutations.
Journal: American journal of respiratory and critical care medicine
Published: July 17, 2018
The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.
Journal: Journal of inflammation research
Published: April 06, 2018
Glycosylation Repurposes Alpha-1 Antitrypsin for Resolution of Community-acquired Pneumonia.
Journal: American journal of respiratory and critical care medicine
Published: November 17, 2017
Brief Report: Genetic Variation of the α1 -Antitrypsin Gene Is Associated With Increased Autoantibody Production in Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 10, 2017
Inhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and function.
Journal: World journal of critical care medicine
Published: November 26, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026